Doubling in median survival in patients diagnosed with multiple myeloma 2005-2019; a real-world study from the UK’s Haematological Malignancy Research Network
Not available.
Saved in:
| Main Authors: | Alexandra Smith, Timothy Bagguley, Eve Roman, Simon Crouch, Russell Patmore, Ruth De Tute, Andy Rawstron, Gordon Cook, Frances Seymour, Christopher Parrish |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-03-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11992 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Wellbeing of the Haematology Workforce in the UK
by: Stewart-Lord A, et al.
Published: (2025-04-01) -
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health Service
by: Rakesh Popat, et al.
Published: (2024-12-01) -
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
by: Graham H Jackson, et al.
Published: (2021-01-01) -
The Power of International Collaboration in Advancing Haematology and Oncology: Fostering Excellence between the UK and Iraq.
by: Ahmed Al-Hassani
Published: (2025-07-01) -
Evaluation of assumed tumour volume in multiple myeloma using dual-energy spectral CT and its correlation between haematological findings
by: Tetsuya Kosaka, et al.
Published: (2025-12-01)